COST-EFFECTIVENESS OF LINACLOTIDE COMPARED TO ANTIDEPRESSANTS IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN SCOTLAND

被引：1
|
作者：
Fisher, M. [1 ]
Falques, M. [2 ]
Rance, M. [3 ]
Taylor, D. C. A. [4 ]
Lindner, L. [2 ]
机构：
[1] WG Consulting Healthcare Ltd, High Wycombe, Bucks, England
[2] Almirall SA, Barcelona, Spain
[3] Almirall UK, Uxbridge, Middx, England
[4] Ironwood Pharmaceut, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1115
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A497 / A497
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland
    Fisher, Mark
    Walker, Andrew
    Falques, Meritxell
    Moya, Miguel
    Rance, Mark
    Taylor, Douglas
    Lindner, Leandro
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (09): : 1091 - 1100
  • [2] Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland
    Mark Fisher
    Andrew Walker
    Meritxell Falqués
    Miguel Moya
    Mark Rance
    Douglas Taylor
    Leandro Lindner
    The European Journal of Health Economics, 2016, 17 : 1091 - 1100
  • [3] COST-EFFECTIVENESS OF LINACLOTIDE (LIN) COMPARED TO ANTIDEPRESSANTS (ATDS) IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) IN SCOTLAND
    Fisher, M.
    Walker, A.
    Falques, M.
    Rance, M.
    Taylor, D.
    Lindner, L.
    GUT, 2014, 63 : A202 - A202
  • [4] Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China
    Xiao, Dunming
    Zhang, Yue
    Chen, Wanxin
    Xuan, Jianwei
    Chen, Yingyao
    ADVANCES IN THERAPY, 2022, 39 (06) : 2971 - 2983
  • [5] Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China
    Dunming Xiao
    Yue Zhang
    Wanxin Chen
    Jianwei Xuan
    Yingyao Chen
    Advances in Therapy, 2022, 39 : 2971 - 2983
  • [6] COST-EFFECTIVENESS OF LINACLOTIDE COMPARED TO OSMOTIC LAXATIVES IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN CHINA
    X'ao, D.
    Zhang, Y.
    Chen, W.
    Xuan, J.
    Chen, Y.
    VALUE IN HEALTH, 2022, 25 (12) : S165 - S165
  • [7] Correction to: Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China
    Dunming Xiao
    Yue Zhang
    Wanxin Chen
    Jianwei Xuan
    Yingyao Chen
    Advances in Therapy, 2022, 39 : 4394 - 4396
  • [8] COST-EFFECTIVENESS OF LINACLOTIDE FOR THE TREATMENT OF ADULT PATIENTS IN THE US WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION
    Huang, H.
    Taylor, D. C. A.
    Carson, R. T.
    Sarocco, P.
    Friedman, M.
    Munsell, M.
    Blum, S., I
    Menzin, J.
    VALUE IN HEALTH, 2013, 16 (03) : A213 - A213
  • [9] COST-EFFECTIVENESS OF LINACLOTIDE: A VALUABLE OPTION IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME
    Almeida, J.
    Vandewalle, B.
    Félix, J.
    VALUE IN HEALTH, 2014, 17 (07) : A366 - A366
  • [10] Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China (vol 39, pg 2971, 2022)
    Xiao, Dunming
    Zhang, Yue
    Chen, Wanxin
    Xuan, Jianwei
    Chen, Yingyao
    ADVANCES IN THERAPY, 2022, 39 (09) : 4394 - 4396
12345